Company news
Tyra Biosciences, Inc. news in 2023
Tyra Biosciences, Inc.'s news releases, calls and decks from 2023, newest first.
Tyra Biosciences Doses First Patient with TYRA-200 and Provides Positive Updates on TYRA-300
December 21, 2023
Tyra Biosciences to Participate in 2023 Jefferies London Healthcare Conference
November 7, 2023
Tyra Biosciences Reports Third Quarter 2023 Financial Results and Highlights
November 6, 2023
Tyra Biosciences Announces Oral Presentations on TYRA-300 for Achondroplasia at the ASBMR and ASHG 2023 Annual Meetings
September 20, 2023
Tyra Biosciences to Participate at 2023 Cantor Global Healthcare Conference
September 11, 2023
Tyra Biosciences Reports Second Quarter 2023 Financial Results and Highlights
August 9, 2023
Tyra Biosciences Announces FDA Orphan Drug Designation for TYRA-300 for the Treatment of Achondroplasia
July 31, 2023
Tyra Biosciences to Participate in Upcoming Investor Conferences
May 24, 2023
Tyra Biosciences Reports First Quarter 2023 Financial Results and Highlights
May 3, 2023
Tyra Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights
March 21, 2023
Tyra Biosciences Expands Development of TYRA-300, an Oral FGFR3 Selective Agent, into Achondroplasia
February 28, 2023